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Adipose stromal cells (ASCs) serve as mesenchymal
progenitors in white adipose tissue (WAT). Intercel-
lular interactions involving ASCs have remained
obscure. By merging phage display technology
with fluorescence-activated cell sorting (FACS), we
screened a combinatorial library for peptides that
target mouse ASCs in vivo. We isolated peptide
CSWKYWFGEC that specifically homes to ASCs,
used it as bait to purify the corresponding ASC
surface receptor, and identified it as a previously
unreported cleavage product of decorin (DCN) lack-
ing the glycanation site (termed DDCN). We demon-
strate that DDCN is differentially expressed on ASC
surface. In a screen for DDCN-binding proteins, we
identified resistin, an adipokine for which the recep-
tor has been unknown. Expression of DDCN in
3T3-L1 cells promoted proliferation and migration
but suppressed lipid accumulation upon adipogene-
sis induction, which was resistin dependent. We
conclude that DDCN serves as a functional receptor
of resistin in adipocyte progenitors and may regulate
WAT expansion.
INTRODUCTION
Adult mammalian tissues harbor multipotent stromal progenitor
cells characterized by their potential for differentiation into cells
of mesodermal lineage (Bianco et al., 2008). Progenitors with
propensity for differentiation into osteoblasts, chondrocytes,
and adipocytes were originally identified in bone marrow (Frie-
denstein, 1980) and this has led to them commonly being
referred to as ‘‘mesenchymal stem cells’’ (MSCs), although
in vivo multipotency of MSCs from certain organs remains to
be proven (Caplan, 1991; Pittenger et al., 1999; Prockop,
1997). There is considerable interest in the clinical application
of MSCs in a range of cell replacement therapies based in
part upon their multipotent differentiation capacity (Giordano
et al., 2007; Kolonin and Simmons, 2009; Rosenzweig, 2006),
on their well-documented immunomodulatory properties (Bar-
tholomew et al., 2002; Jones and McTaggart, 2008; Le Blanc
et al., 2003), and on accumulating evidence of the trophic activ-
ities of MSCs in tissue repair and regeneration through the74 Cell Stem Cell 9, 74–86, July 8, 2011 ª2011 Elsevier Inc.secretion of bioactive molecules that regulate a range of cellular
activities, including apoptosis, cell proliferation, and vasculari-
zation (Rehman et al., 2004; Traktuev et al., 2009; Wagner
et al., 2009).
White adipose tissue (WAT) represents a large reservoir of
adipose stromal cells (ASCs) (Gimble et al., 2007). While adipo-
cytes are the primary cell type in WAT, ASCs comprise the
majority of cells in the stromal/vascular fraction (SVF), which
also contains endothelial cells (ECs) and infiltrating hematopoi-
etic cells (Daquinag et al., 2011; Hausman et al., 2001). ASCs
have been revealed as a rich source of progenitors that, ex vivo,
display multipotency and proliferation capacity comparable to
those of bone marrow MSCs (Rodeheffer et al., 2008; Tang
et al., 2008; Zuk et al., 2001). The clinical potential of ASCs based
on their effective cooperation with ECs (Traktuev et al., 2008,
2009), as well as their potential implication in pathology (Zhang
et al., 2009), has also been recognized. Although heterogeneous
in terms of their capacity for proliferation and differentiation, cells
with the phenotypic characteristics of MSCs exhibit a common
anatomic location as perivascular cells in many tissues,
including WAT (Crisan et al., 2008; Sacchetti et al., 2007; Tang
et al., 2008; Traktuev et al., 2008). The lack of defined cell surface
markers unambiguously identifying stromal cells (Bianco et al.,
2008; Gimble et al., 2007; Simmons and Torok-Storb, 1991)
has suggested that these mesenchymal perivascular cells have
different features in different organs.
Here, we took a step toward characterization of molecular
interactions taking place at the ASC surface. By using
phage display, we screened combinatorial libraries for peptides
binding to differentially expressed circulation-accessible stro-
mal cell molecules in live mice. We isolated a cyclic peptide
(amino acid sequence CSWKYWFGEC), termed WAT7, that
homes to ASCs but not to stromal cells in other organs when
administered systemically. We used WAT7 as bait to biochemi-
cally purify the corresponding ASC surface receptor and identi-
fied it as a previously overlooked isoform of decorin (DCN)
protein, a proteolytic cleavage fragment lacking a glycanation
site. We show that this N-terminally truncated DCN, which we
termed DDCN, is highly expressed by ASCs and is exposed
on the cell surface, and thus can be used as an ASC marker.
Finally, in a screen for proteins mimicked byWAT7, we identified
resistin (also known as adipocyte-specific secretory factor, or
ADSF) as a protein that serves as an endogenous ligand of
DDCN in WAT. Because ectopic expression of DDCN in preadi-
pocytes induces a phenotype previously reported for effects of
resistin, we propose that resistin-DDCN signaling regulates the
fate of ASCs.
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Figure 1. A Screen for Stromal Cell-Homing Peptides
(A) Scheme of a screen for peptides homing to organ-specific stromal cell
populations. A mixture of three phage-displayed cyclic peptide libraries was
used for four rounds of synchronous multiorgan biopanning in mice. In
every selection round, FACS was used to deplete erythroid (TER119+),
endothelial (CD31+), and hematopoietic (CD45+) cells and to collect
CD34+CD31CD45 stromal cells from WAT, lung, bone marrow, and
skeletal muscle.
(B) Phage peptides bound to ASCs, in parallel with phage peptides bound to
stromal cells of control organs, were quantified, amplified, pooled, and used
for the next round of biopanning. Increased recovery of phage transforming
units (TU) in successive rounds reflects the enrichment of phage peptides
homing to stromal cells of individual target organs.
(C) Relative specificity of ASC homing assessed for individual phage-peptide
clones separately injected into mice as a ratio of TU recovered on WAT
CD34+CD31CD45 cells to TU recovered on lung CD34+CD31CD45
cells. Fd-Tet: control insertless phage. Shown are mean ± SD for triplicate
measurements.
See also Figure S1.
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A Screen for ASC-Homing Peptides
We hypothesized that phage can extravasate through the endo-
thelium and home to pericytes/stromal cells when delivered
systemically, which should enable the selection of phage-
displayed peptides homing to stromal cells. We have combined
our expertise in phage display (Kolonin et al., 2002, 2004, 2006a;
Nie et al., 2008) with the methods for isolation of MSCs by
fluorescence-activated cell sorting (FACS) from organ cell sus-
pensions (Figure 1A). We focused on the CD34+CD31CD45
immunophenotype (Figure S1B available online) previously re-
ported for a perivascular stromal cell subpopulation in mouse
WAT (Tang et al., 2008; Traktuev et al., 2008; Zhang et al., 2009)
and in other organs (Bellows et al., 2011; Copland et al., 2008;
da SilvaMeirelles et al., 2006; Zimmerlin et al., 2010). By adapting
the previously described ‘‘synchronous in vivo biopanning’’
method (Kolonin et al., 2006b), we screened a mixture of cyclic
CX7C, CX8C, and CX9C (C: disulfide-bonded cysteines; X: any
amino acid) random peptide libraries (Figure S1A). This approach
makes it possible to select stromal cell probes from the pool of
over 1011 combinatorial peptides displayed from the pIII protein
of filamentous M13 bacteriophage. In round 4 of the screen, we
observed enrichment in the number of phage particles recovered
on stromal cells from WAT, and from the chosen control organs:
lung, bone marrow, and skeletal muscle (Figure 1B). Sequencing
of DNA coding for peptide inserts revealed selection of clones
from CX7C and CX8C libraries, whereas clones from the CX9C
library have been predominantly lost, possibly due to propagation
disadvantage of phage containing longer peptide inserts in the pIII
protein.
After four rounds of synchronous in vivo biopanning, we iden-
tified eight CX7C and CX8C sequences repeatedly recovered
from ASCs with frequency above 1%, which were termed
WAT1 through WAT8 (Figure S1C). In parallel, we sequenced
a matched number of peptide inserts homing to lung stromal
cells (LSCs) as a control. None of the WAT-homing peptides
were enriched in the lung. Four sequences repeatedly recovered
in the lung with frequency above 1% were termed LU1 through
LU4 (Figure S1C). Comparative analysis of individual phage
clones in vivo revealed WAT7, homing to ASCs 1000 times
more efficiently than to LSC, as a peptide with the highest spec-
ificity for ASCs (Figure 1C). Clone WAT8 displayed modest pref-
erence for ASCs as compared to LSCs at a level similar to mPep,
a previously characterized peptide mimicking the secreted
protein acidic and rich in cysteine (SPARC), also known as os-
teonectin (Nie et al., 2008). Consistent with this observation,
the sequence of WAT8 peptide (CGQWLGNWLC) was found to
be similar to mPep (CWLGEWLGC), indicating integrin b1,
a previously established marker of MSCs, as a likely receptor
for WAT8 peptide. Because the focus of this study is WAT-
specific stromal cells, we excluded this clone from further anal-
ysis. We subjected the other selected peptides to an in vivo
competition assay in order to identify those with the highest
specificity of binding. Equal amounts of phage for the 11 clones
displaying peptides WAT1 through WAT7 and LU1 through LU4
were admixed and injected into a mouse. Homing specificity of
each clone was assessed by quantifying frequency of phage
coding for each peptide selected on CD34+CD31CD45 cellsisolated from either WAT or lung. Consistent with data above
(Figure 1C), peptide WAT7 stood out based on its marked
capacity to rehome to WAT cells: it represented 87.4% of clones
recovered from WAT and only 5.8% of clones recovered
from lung. Reciprocally, clones LU1 and LU2 (sequence of theCell Stem Cell 9, 74–86, July 8, 2011 ª2011 Elsevier Inc. 75
A B
C D
E F
G H
I J
Figure 2. Validation of WAT7 Peptide Homing to ASCs
(A–D) Confocal anti-phage (red) and anti-CD31 (green) immunofluorescence in
serial paraffin sections of formalin-fixedWAT and lung frommice intravenously
injected with phage displaying WAT-homing peptide WAT7 (arrow) or a lung-
homing peptide LU2 (arrowhead). Red signal upon digital channel merging
indicates localizationof phageonnonendothelial perivascular cells observed for
WAT7 in WAT (A), but not in lung (B), and for LU2 in lung (D), but not in WAT (C).
(E–J) Biodistribution of biotinylated peptide WAT7 1 hr postintravenous
injection revealed by confocal microscopy detecting streptavidin-Cy3 (red)
and contrasted with tissue expression of PDGFRb (red), CD31 (green), and
CD45 (green) detected by immunofluorescence on serial tissue sections. Note
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40.2%, respectively), but not to WAT (Figure S1C).
Validation of CSWKYWFGEC as a Peptide Targeting
ASCs
Based on the combined homing data, peptide WAT7, showing
the most definitive ASC-targeting, was chosen for further anal-
ysis. Peptide LU2 was chosen as a control peptide targeting
stromal cells in the lung. We validated homing of WAT7 by
analyzing biodistribution of WAT7-displaying phage upon intra-
venous injection. Distribution of phage in relationship to ECs
was examined using phage-specific and EC-specific antibodies.
Immunofluorescence in mouse tissue sections demonstrated
that phage accumulation was associated with the stroma/vascu-
lature of WAT (Figure 2A), but not of lung (Figure 2B) or other
control organs. Reciprocally, LU2 accumulation was associated
with the stroma/vasculature of lung (Figure 2D), but not of WAT
(Figure 2C). To validate the capacity of peptides to home outside
the phage context, we biotinylated chemically synthesized cyclic
WAT7 and LU2. Intravenous administration of each peptide into
mice followed by immunofluorescence analysis of tissues with
streptavidin-conjugated fluorophore reproduced selectivity of
WAT7 for WAT (Figure 2). Costaining with antibodies against
CD31 marking ECs and antibodies against platelet-derived
growth factor receptor-b (PDGFRb, CD140b) marking pericytes
was performed to identify the target cell population. Confocal
imaging revealed perivascular localization of WAT7 in associa-
tion with PDGFRb+ cells (Figures 2E–2H) that have been previ-
ously established as ASCs (Crisan et al., 2008; Tang et al.,
2008; Traktuev et al., 2008). Importantly, WAT7 did not colocal-
ize with either ECs (Figure 2E) or WAT-infiltrating CD45+ hema-
topoietic cells (Figure 2G). Consistent with the data on phage bi-
odistribution, WAT7 peptide was not detected in lungs of
injected animals (Figure 2I), despite the abundance of pericytes
revealed by PDGFRb immunofluorescence (Figure 2J).
In agreement with in vivo homing data, phage-displaying
WAT7 showed high level of specific binding to primary nonpas-
saged ASCs, but not to LSCs isolated from the same animal,
3T3-L1 mouse preadipocytes, or 4T1.2 mouse adenocarcinoma
cells (Figure S2A). While WAT7 did not bind to human ASCs that
had undergone several ex vivo passages, it displayed binding to
unpassaged SVF cells from human WAT (Figure S2B). To deter-
mine whether ASCs recognized by WAT7 correspond to the
adipocyte progenitor population, we used this peptide to pull
down the target ASC subpopulation from the SVF of mouse
WAT. According to three independent experiments, these cells
represented 27% ± 7% of the SVF and uniformly had MSC
morphology (Figure S2C). As expected, SVF that did not bind
WAT7 appeared heterogeneous (Figure S2C) due to the pres-
ence of ECs, leukocytes, and possibly stromal cells lacking
WAT7 receptor. We demonstrated that the WAT7-selected
stromal cell subpopulation indeed corresponds to progenitorthe association (arrow) of WAT7 specifically with perivascular WAT cells (E) in
a pattern overlapping with PDGFRb expressed on ASCs (F). Like PDGFRb,
WAT7 is not associated with CD31+ ECs (E) or CD45+ hematopoietic cells
(G and H). WAT7 is not detected in lung (I) despite the abundance of PDGFRb+
LSCs (J). Nuclear TOPRO3 staining is blue.
Scale bar: 100 mM. See also Figure S2.
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upon adipogenic induction as compared with the SVF cells
that did not bind to WAT7 (Figure S2D).
As an additional validation of WAT7 targeting ASCs in vivo, we
demonstrated its localization to perivascular cells expressing
alpha-smooth muscle actin (aSMA) by confocal microscopy
(Figure S3A). By examining SVF cells isolated from WAT7-
injected animals by immunofluorescence, we further confirmed
association of WAT7 with ASCs identified in culture as fibro-
blastic CD31aSMA+ cells, but not with CD31+aSMA ECs
or macrophages (Figures S3B and S3C).
Isolation of CSWKYWFGEC Receptor
To identify the receptor for the ASC-homing peptide WAT7, we
used affinity chromatography based on the methods we have
previously established (Kolonin et al., 2004; Nie et al., 2008).
Membrane proteins were extracted from the SVF of mouse
WAT and applied to cysteine-cyclized synthetic WAT7 cova-
lently coupled to resin through its C terminus. For elution,
WAT2 peptide (sequence CYKNVDSGGC) was first used to
remove nonspecifically bound proteins (Figure 3A). Specifically
bound proteins were then eluted with WAT7 and appeared in
a discrete subset of fractions. A WAT2 peptide affinity column
was used in parallel to confirm specificity of affinity purification.
Testing of desalted eluates coated onto plastic for phage-
peptide binding confirmed that fractions purified using WAT7
contained proteins binding to WAT7-displaying phage, but not
to control WAT2-displaying phage (Figure 3B). Fractions eluted
with WAT7 from a control affinity column loaded with WAT2
and exposed to the same membrane protein extract were not
significantly bound byWAT7-displaying phage (Figure 3B). Frac-
tion 5, containing proteins pulled down and specifically eluted
with WAT7, showed the highest level of binding by WAT7-
displaying phage and was chosen for receptor purification.
Proteins eluted in this fraction were concentrated and resolved
by denaturing gradient polyacrylamide gel electrophoresis
(PAGE). A band specifically eluted with WAT7, but not with the
control peptide WAT2, migrated at approximately 40 kDa (Fig-
ure 3C). Mass spectrometric analysis of this band revealed that
it contained DCN, alternatively known as proteoglycan II. This
molecular weight corresponds to DCN core protein (Imai et al.,
1997; Roughley et al., 1996), suggesting that WAT7 binds to
DCN lacking the dermatan/chondroitin sulfate glycosamino-
glycan (GAG) chain (nonglycanated). G protein beta subunit
(GNB1), a voltage-dependent anion channel 1 (VDAC1), and
isochorismatase domain-containing protein 1 (ISOC1) were
identified in the three lower molecular bands eluted with WAT7.
DCN is an extensively studied molecule secreted into the
extracellular matrix (ECM) and controlling several physiological
processes (Day et al., 1987; Krusius and Ruoslahti, 1986; Reed
and Iozzo, 2002; Scholzen et al., 1994). Its ubiquitous mRNA
expression appeared inconsistent with WAT7 homing to ASCs
in WAT. To analyze DCN protein expression in mouse organs,
we subjected a panel of mouse tissue sections to confocal
immunofluorescence with commercially available antibodies
raised against full-length glycanated mouse DCN. Consistent
with previous studies (Bolton et al., 2008), DCN protein was
detectable in many organs; however, it was particularly highly
abundant in WAT as compared with lung and bone marrow(Figures 4A–4C; Figures S4A–S4C). This was in striking contrast
with expression of PDGFRb that was detectable in all organs, as
assessed in parallel (Figures 4D–4F; Figures S4A–S4C). Our data
show that both DCN and PDGFRb are expressed by WAT peri-
vascular ASCs surrounding CD31+ endothelium (Figures 4A
and 4D; Figures S4A and S4B). However, DCN expression in
other organs (Figure 4) suggested that differences in DCN
expression level by stromal cells in different organs might not
be sufficient to account for WAT7 homing to ASCs.
To quantify DCN expression in WAT, we subjected protein
extracts from mouse tissues to immunoblotting with the anti-
DCN antibodies (Figure 5A; Figure S4C). Analysis of soluble
proteins from the SVF fraction of WAT, as well as from lung
and femoral bone, showed comparable expression of higher
molecular weight glycanated DCN isoforms. In contrast, WAT
displayed increased expression of an 40 kDa nonglycanated
core DCN (Figure 5A). Interestingly, immunoblotting analysis of
membrane proteins from the three organs revealed WAT-
specific expression of a DCN isoform with a molecular weight
lower than that of the nonglycanated core DCN previously char-
acterized in other organs (Figure 5A). We further used immuno-
blotting to investigate which tissues and cells in WAT express
the low-molecular weight DCN isoform. Our data indicate that
it associates selectively with themembrane (but not with soluble)
fraction of ASCs, but not with that of differentiated adipocytes
(Figure S4C).
A Previously Unknown DCN Isoform Is the
CSWKYWFGEC Receptor
To establish the identity of theWAT-specific DCN isoform, which
we termed DDCN, we used the DCN antibodies to purify DCN
from the membrane extract of the WAT SVF. Analysis of immu-
noprecipitated proteins by denaturing PAGE revealed the ex-
pected 40 kDa band corresponding toDDCN (Figure 5B). Edman
degradation microsequencing of the protein from the cut out
band revealed that this DCN fragment starts at Leu-45 (Fig-
ure 5C), and is therefore 14 amino acids shorter than the previ-
ously described mature core DCN generated after propeptide
cleavage (Imai et al., 1997; Roughley et al., 1996). Therefore,
DDCN cannot be glycanated because it is missing the GAG
attachment site SerGly (Figure 5C) present in core DCN (Schol-
zen et al., 1994). Lack of methionine as the N-terminal residue
in DDCN suggests that it is generated by proteolytic cleavage
rather than by alternative splicing.
To validate DCN as the target of WAT7, we performed
enzyme-linked immunosorbent assays (ELISA) with His6-tagged
proteins. These in vitro binding studies demonstrated clear
dose-dependent binding of WAT7 to purified, bacterially ex-
pressed mouse DDCN, as well as to bacterially expressed (and
therefore nonglycanated) mouse core DCN (Figure 5D), while
the control peptide WAT2 did not display DCN binding (Fig-
ure S4D). Interestingly, WAT7 did not bind to either bovine or
mouse glycanated DCN significantly better than it did to bovine
serum albumin (BSA) control (Figure 5D), suggesting that the
GAG chain on mature DCN prevents WAT7 binding. We
confirmed this by showing that DCN immunoprecipitated from
mouse bones and skeletal muscle can bind to WAT7 upon
GAG removal with chondroitinase ABC (Figure S5). These obser-
vations explain why ubiquitous secretion of glycanated DCN intoCell Stem Cell 9, 74–86, July 8, 2011 ª2011 Elsevier Inc. 77
AC
0
5
10
15
20
25
30
35
40
45
1 2 3 4 5 6 7 8 9 10 11 12
250
150
100
75
50
37
25
20
kDa WAT2 
WAT7 affinity 
WAT7 
B
0
0.05
0.1
0.15
0.2
0.25
0.3
1 2 3 4 5 6 7 8 9 10 11 12
O
D 
59
5 
WAT2 WAT7 glycine
1 2 3 4 5 6 7 8 9 10 11 12
WAT2 glycineWAT7 
WAT7 affinity WAT2 affinity 
affinity / phage 
Figure 3. Purification of the ASC Receptor for WAT7
(A) Cysteine-cyclized synthetic peptides WAT7 and WAT2 (control) covalently linked to EDC Sepharose were incubated with mouse SVF membrane protein
extract. After washing, proteins bound to WAT7 or WAT2 affinity column were consecutively eluted with WAT2, WAT7, and 0.1 M glycine (pH 2.5) as indicated.
Protein concentration in each fraction was measured by Bradford assay and plotted as OD595 absorbance.
(B) Desalted proteins from each fraction were coated on plastic and exposed to phage displaying WAT7 or WAT2 as indicated. Phage binding was quantified
based on TU recovery upon host bacteria infection: increased WAT7-phage binding for WAT7 affinity fraction 5 indicates elution of a WAT7-binding protein.
(C) Proteins fromWAT7 affinity fractions 1 (control) and 5 were resolved by gradient 4%–15% SDS-PAGE. Coomassie staining of the gel demonstrates a 40 kDa
band (arrow) specifically eluted with WAT7 identified as DCN. Three other WAT7-eluted bands are indicated with arrowheads.
See also Figure S3.
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not interfere with WAT homing of the WAT7 peptide.
DDCN Is Expressed on ASC Surface
In order to serve as a receptor for WAT7, DDCN must be
exposed on the surface of ASCs. We used several approaches
to confirm that DDCN is displayed on the cell membrane. The
surface proteins of freshly isolated WAT SVF cells were biotiny-78 Cell Stem Cell 9, 74–86, July 8, 2011 ª2011 Elsevier Inc.lated as described (Kolonin et al., 2004), isolated by using
streptavidin beads, and subjected to anti-DCN immunoblotting.
As expected, DDCN was isolated, indicating its association
with the cell surface (Figure 5E). Interestingly, overnight
culturing of WAT SVF cells on plastic in conditions typically
used for MSC/ASC propagation resulted in the disappearance
of DDCN from the pool of cell surface proteins (Figure 5E). By
fractionating total cell proteins of the SVF, we demonstrated
WAT
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Figure 4. Perivascular DCN Expression in WAT
Confocal immunofluorescence on serial sections of formalin-fixed paraffin-embedded mouse tissues with anti-DCN or anti-PDGFRb antibodies (red) counter-
stained with anti-CD31 antibodies (green) demonstrating that both DCN (arrows) and PDGFRb (arrowheads) are expressed on perivascular ASCs in WAT (A and
D). DCN expression is found in association with only a fraction of vessels in lungs (B) and is expressed in bone and skeletal muscle, while it is undetectable in bone
marrow (C). In contrast, PDGFRb is ubiquitously expressed by the stroma of lung (E) and bonemarrow (F). Blue: nuclear TOPRO3 staining. Scale bar: 100 mM. See
also Figure S4.
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taining Na-K ATPase, but not with the soluble protein fraction
containing GAPDH (Figure 5F). We also analyzed cellular local-
ization of DDCN recombinantly fused with the green fluorescent
protein (GFP) expressed in 3T3-L1 preadipocytes by using len-
tivirus. Confocal immunofluorescence with antibodies against
GFP and hyaluronan receptor CD44 (marking MSC surface)
on fixed nonpermeabilized cells confirmed colocalization
DDCN-GFP and CD44 signal, and therefore the presence of
DDCN on the cell surface (Figure 5G). Topographical confocal
microscopy analysis confirmed colocalization of DDCN-GFP
and CD44 (Figure S6A). In contrast, full-length DCN-GFP was
not detectable on the cell surface in this assay (Figure 5G).
Control immunofluorescence experiments were also performed
to demonstrate that GFP signal was not detected in nontrans-
duced 3T3-L1 cells (Figure S6B). We excluded the possibility of
DDCN-GFP signal resulting from intracellular antibody pene-
tration by demonstrating lack of reactivity of antibody against
an endoplasmic reticulum (ER) marker calreticulin on non-
permeabilized cells, while calreticulin was readily detectible in
the ER of permeabilized cells (Figure S6B). Finally, we exposed
DDCN-expressing 3T3-L1 cells to biotinylated WAT7 peptide
prior to washing and immunofluorescence analysis. This
revealed colocalization of WAT7 foci with DDCN (Figure S6C).
Provided WAT7 did not bind to cells transduced with GFP
alone or full-length DCN-GFP fusion (Figure S6C), these data
collectively indicate that exposure of DDCN on ASCs takes
place in vivo and that DDCN is the cell surface receptor
of WAT7.Resistin Is the ASC Interactor of DDCN
We set out to investigate the biological interaction behind the
WAT7-DDCN binding. Our previous studies have shown that
peptides tend to recognize cell surface receptors through
mimicking receptor-binding domains of the biological ligands
for these receptors (Arap et al., 2002; Kolonin et al., 2006a,
2006b). In order to identify the biological ligand of DDCN, we
raised antibodies against WAT7, which we expected to recog-
nize the binding epitope of a mouse protein mimicked by
WAT7. Figure 6A demonstrates that the generated WAT7 anti-
bodies have high specificity for WAT7 and do not recognize
any of the other ASC-homing peptides isolated in the screen.
Immunoblotting of mouse protein extracts identified an
13 kDa protein recognized by WAT7 antibodies (Figure 6B).
This protein was highly abundant in freshly isolated WAT tissue,
but not in lung or bone marrow. Interestingly, its expression was
lost upon overnight ASC culturing on plastic in conditions typi-
cally used for MSC/ASC propagation (Figure 6B). This is coinci-
dent with the loss of DDCN cell surface expression in culture
(Figure 5E), suggesting that DDCN exposure on ASCs is coupled
with expression of its ligand.
To isolate the DDCN ligand from WAT, we immobilized anti-
WAT7 immunoglobulins (IgG) on Protein A/G beads and per-
formed affinity chromatography. The products of the affinity-
capture were resolved by PAGE (Figure 6C), after which the
13 kDa band was cut out. Mass spectroscopy identified the
protein as resistin, which is known to function as aWAT-secreted
adipokine (Steppan et al., 2001). ClustalW software-assisted
amino acid sequence analysis revealed that 5 out of 10 WAT7Cell Stem Cell 9, 74–86, July 8, 2011 ª2011 Elsevier Inc. 79
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Figure 5. A Cleavage Fragment of DCN Is the WAT7 Receptor on ASCs
(A) Immunoblotting of membrane-associated and soluble proteins extracted from mouse tissues with DCN antibodies. Indicated are DDCN expressed specif-
ically in SVF of WAT (arrow), nonglycanated (ng) core DCN (arrowhead), and glycanated DCN (g). Probing the gel with antibodies against annexin II (ANX2A) was
used to control for protein loading.
(B) Affinity purification of DDCN frommembrane WAT SVF extract. Gel Coomassie staining identified the expected 40 kDa band (arrow) between light and heavy
chains of the anti-DCN IgG.
(C) N-terminal Edman degradation microsequence of DDCN isolated in (B) aligned with N-termini of full-length mouse and human DCN. Previously reported sites
of protease cleavage (arrows), resulting in the processing of propeptide and core DCN, and the GAG attachment site (g), are indicated. Sequence corresponding
to amino acids 56–354 of mDCN is not shown.
(D) Measurement of WAT7 binding to purified bacterially expressed mouse DDCN, bacterially expressed full-length core mouse DCN (mDCN), full-length
glycosylated mouse DCN (mDCNg), glycosylated bovine DCN (bDCNg), and BSA by ELISA. OD450 absorbance, plotted as a function of peptide concentration,
shows dose-dependent DDCN-WAT7 and mDCN-WAT7 binding. Shown are mean ± SD for triplicate wells; *p < 0.01 for WAT7 binding versus BSA.
(E) Exposure of DDCN on the surface of mouse ASCs assessed through treatment of cells with a biotinylation reagent. Biotinylated proteins (isolated with
streptavidin beads) were subjected to anti-DCN immunoblotting, revealing DDCN (arrow) undergoing biotinylation on freshly isolated, but not on cultured, ASCs.
(F) Anti-DCN immunoblotting of total, soluble, and cell membrane protein fractions isolated from mouse WAT SVF showing that DDCN (arrow) is associated with
cell membrane. Antibodies against Na-K ATPase and GAPDH were used as fractionation controls.
(G) 3T3-L1 cells transduced with lentivirus expressing mouse DDCN-GFP or full-length DCN-GFP fusions were fixed, and without being rendered permeable,
were subjected to confocal immunofluorescence with anti-GFP (green) and anti-CD44 (red) antibodies. Z-stack projections of median series demonstrate
localization of the DDCN-GFP on the cell surface positive for CD44. Nuclear DRAQ5 staining is in blue.
Scale bar: 10 mM. See also Figures S5 and S6.
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Figure 6. WAT7 Binds to DDCN by Mimicking Resistin
(A) Top: Coomassie staining of a gel demonstrating purification of GST (1) and recombinant GST-fused peptides WAT1 (2), WAT2 (3), WAT7 (4), and LU2 (5),
analyzed in parallel with the following GST-fused controls: CKGGRAKDC peptide (6), prohibitin protein (7), and CWLGEWLGC peptide (8). Middle: immuno-
blotting of the same gel with anti-WAT7 antibodies. Bottom: immunoblotting of the same gel with preimmune serum from a rabbit used for generation of anti-
WAT7 antibodies.
(B) Immunoblotting of total proteins extracted from mouse cultured 3T3-L1 fibroblasts, cultured ASCs, cultured LSCs, and cells freshly isolated fromWAT, bone
marrow, or lungs with anti-WAT7 antibodies detects a specific 13 kDa protein (arrowhead).
(C) Affinity purification of mouse proteins with anti-WAT7 antibodies from WAT extract. Gel Coomassie staining reveals the same 13 kDa protein, identified as
resistin, relative to light (L) and heavy (H) chains of the anti-WAT7 IgG.
(D) ClustalW software-assisted alignment of WAT7 and the indicated resistin fragment amino acid sequences.
(E) Measurement of FLAG-tagged resistin and control protein (bovine alkaline phosphatase) binding to bacterially expressed mouse DDCN, as compared to
bacterially expressed full-length mouse DCN (mDCN), a control His6-tagged protein CLIC4 (Ctrl-prot), glycosylated mouse DCN (mDCNg), glycosylated bovine
DCN (bDCNg), and BSA by ELISA. OD450 absorbance, plotted as a function of FLAG-tagged protein concentration, shows dose-dependent DDCN/resistin
binding. Shown are means ± SD for triplicate wells; *p < 0.05 for DDCN versus BSA.
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thorough its 25 amino-acid segment (Figure 6D), suggesting
that WAT7 mimics this resistin domain. Because resistin interac-
tionwith DCN has not been previously reported, to test whether it
interacts with DDCN directly, we performed in vitro binding
assays with FLAG-tagged mouse resistin. FLAG-tagged bovine
alkaline phosphatase (BAP) served asanegative control. Resistin
was found to bind to DDCN at a 100-fold lower molar concentra-
tion than it did to full-length DCN (Figure 6E). Like WAT7, resistin
was inefficient in binding to glycanatedmouse or bovine DCN, as
evident from its comparable background BSA and BAP binding.
These results indicate that resistin serves as a ligand of DDCN.
Functional Analysis of DDCN-Resistin Interaction
To investigate the function ofDDCN, we used the 3T3-L1 cell line
as amodel widely accepted for studying the biology of adipocyteprogenitors. We used the established 3T3-L1 cultures lentivirally
transduced with DDCN-GFP or full-length DCN-GFP fusions;
GFP vector alone was used as a control (Figure 5G). Analysis
of cell number increase after 24 hr and 48 hr in culture using
the MTT assay demonstrated increased proliferation of cells ex-
pressing DDCN, compared with cells expressing GFP or full-
length DCN-GFP (Figure 7A). Analysis of cell migration by using
the Boyden chamber transwell assay demonstrated a significant
increase in the motility of DDCN-expressing cells, while cells
expressing full-length DCN showed the opposite trend,
compared with cells expressing GFP (Figure 7B). These results
were confirmed by the in vitro scratch wound assay (data not
shown). To test the effect on cell differentiation, we subjected
the cells to adipogenesis induction (Figure 7C). While GFP vector
alone did not interfere with adipogenic differentiation, formation
of large lipid droplets in DCN-expressing cells was inhibited.Cell Stem Cell 9, 74–86, July 8, 2011 ª2011 Elsevier Inc. 81
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Figure 7. Effects of DDCN Ectopic Expression in Preadipocytes
Functional assays performed on 3T3-L1 cells stably transduced with lentivirus expressing GFP (vector), mouse DDCN-GFP fusion (DDCN), or full-length core
mouse DCN-GFP fusion (DCN) in medium containing 10% FBS (A–C) or upon depletion of FBS resistin with anti-WAT7 antibodies (resistin) or upon adding
500 ng/ml mouse resistin (+ resistin) to the depletedmedium (D–F). (A and D) Proliferation of 5000 adherent cells at the indicated time points measured by theMTT
assay. (B and E) Migration of prestarved cells through 5 mM pores toward indicated medium measured by the Transwell assay. After 12 hr, cells at the bottom of
the transwell were fixed, stained, and counted. (C and F) Lipid droplet accumulation assessed by phase contrast microscopy 10 days (C) or 4 days (F) after
induction of adipogenesis in indicated medium. In (C) cells were stained with Oil red O. In (F) differentiating phase-bright, lipid droplet-laden adipocytes are
indicated with arrowheads. A defect in lipid accumulation in DDCN-expressing cells manifested by accumulation of abnormal vacuoles (arrow) is prevented by
resistin depletion from FBS and exacerbated by addition of mouse resistin. Shown are means ± SD of triplicate wells; *p < 0.05. Scale bar: 10 mM. See also
Figure S7.
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inhibited the formation of large lipid droplets. Finally, we tested
whether addition of exogenous mouse resistin would enhance
the DDCN-mediated effect of bovine resistin (supplied with
bovine serum). In a reciprocal experiment, we depleted bovine
resistin from FBSwithWAT7 antibodies (Figure S7). As observed
for DDCN-expressing cells, extra resistin further promoted cell
proliferation (Figure 7D) and migration (Figure 7E). The reverse
was observed for adipocyte differentiation: depletion of resistin
partially restored normal lipid accumulation, whereas extra
resistin exacerbated the lipogenesis defect (Figure 7F). Com-
bined, these data indicate that DDCN activates a cellular pro-82 Cell Stem Cell 9, 74–86, July 8, 2011 ª2011 Elsevier Inc.gram favoring proliferation and migration of adipocyte progeni-
tors, while at the same time affecting the lipogenesis/lipolysis
program.
DISCUSSION
Lack of information on surface molecules expressed by stromal
cells in different organs has limited our understanding of the
mechanisms through which interactions of MSCs with other
tissue components mediate tissue development, remodeling,
and regeneration. We had previously initiated a systematic
screen for molecular interactions occurring at the surface of
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Resistin-Decorin Interaction Marks Adipose MSCsstromal cells and reported integrin b1 as a receptor of SPARC
(Nie et al., 2008). Here, we moved forward the technology for
unbiased identification of tissue-specific interactions occurring
at the cell surface by combining phage display library screening
in mice with FACS. In this approach, we screened a complex
mixture of combinatorial libraries on cells derived from a panel
of mouse organs based on the CD34+CD31CD45 marker
signature specific for a perivascular subpopulation of stromal
cells. As a result, we isolated peptide WAT7, which, when in-
jected in vivo, targets ASCs, but not stromal cells in lung, bone
marrow, or skeletalmuscle.Webiochemically purified a fragment
of DCN, termed DDCN, as the receptor for WAT7. We show that
this previously unreported DCN isoform, lacking theGAG attach-
ment site and therefore being nonglycanated, is highly ex-
pressed in ASCs and is exposed on their surface. Interestingly,
WAT7 localizes to the surface of ASCs that face away from the
blood vessel (Figure S3A). This suggests that DDCN, also local-
ized on these ASC surface domains (Figure S4A), may be
involved in interaction with interstitial ECM and adipocytes. We
identify resistin as a protein directly binding to DDCN, but not
to glycanated full-length DCN. Finally, our data indicate that
ectopic DDCN expression and resistin induce similar physiolog-
ical responses in adipocyte progenitors, confirming their func-
tional interaction. Because resistin-dependent phenotypes are
specifically observed for DDCN-expressing cells, but not for
full-length DCN-expressing cells, we conclude that resistin
signals through DDCN in adipocyte progenitors.
DCN is a secreted multifunctional proteoglycan that plays
a role in cell adhesion, proliferation, and migration: the pro-
cesses underlying angiogenesis and fibrosis (Ferdous et al.,
2010; Fiedler et al., 2008; Ja¨rvela¨inen et al., 2006). It controls
the development of mammalian connective tissue and is also
implicated in a number of pathological conditions (Reed and
Iozzo, 2002). One of the established DCN functions is to mediate
the assembly of collagen-I into functional fibers (Danielson et al.,
1997; Reed and Iozzo, 2002). DCN inhibits ECM-integrin interac-
tions and has been shown to control vascular remodeling asso-
ciated with inflammation (Nelimarkka et al., 2001). While the
function of DCN is not restricted to a particular organ, in line
with our findings, a high level of perivascular DCN expression
by the SVF of WAT was recently reported (Bolton et al., 2008).
Importantly, the study by Bolton et al. uncovered association
of adipose DCN expression with obesity and type 2 diabetes,
suggesting a role for this protein in WAT biology. While proteo-
lytic degradation of DCN has been characterized, and a number
of metalloproteinase cleavage sites have been mapped (Imai
et al., 1997; Roughley et al., 1996), DCN processing that leads
to DDCN has not been previously reported. Future studies may
help to establish the enzymatic reaction responsible for the
formation of this isoform.
Association of DCNwith the plasmalemma has not been previ-
ously reported, although there is evidence that DCN can be
localized to the cell surface in certain physiological contexts
(Iozzo et al., 1999; Scho¨nherr et al., 2005). Because DCN lacks
a defined transmembrane domain (Scott et al., 2004; Weber
et al., 1996), it is unlikely that DDCN processed inside the cell
is directly incorporated into the ASC membrane. The reported
protein interactions involving DCN help put our findings into
perspective. It has been shown that DCN binds to epidermalgrowth factor receptor (EGFR) and IGF-I receptor (IGFR) on the
cell surface (Iozzo et al., 1999; Scho¨nherr et al., 2005). Therefore,
it is possible that DDCN associates with the cell surface upon
extracellular secretion via binding to EGFR and/or IGFR. Alterna-
tively, DDCN could directly bind to ASC surface upon secretion.
The 3D structure of DCN (Scott et al., 2004; Weber et al., 1996)
indicates that its leucine-rich repeats organize into a charged
surface that could mediate polar binding to charged molecules
in the cell membrane. Because DDCN lacks the dermatan/chon-
droitin sulfate GAG, which modifies core DCN protein, the
charge difference and/or the steric conformation change
imposed by glycosylation could account for the unique binding
properties of DDCN.
In a search for biological ligands binding to DDCN on ASC
surface, we have considered as candidates extracellular
proteins that have been reported to interact with DCN. In addi-
tion to collagen-I, DCN has been reported to bind transforming
growth factor (TGF-b), which leads to context-dependent modu-
lation of TGF-b activity (Hildebrand et al., 1994). Because TGF-b
is a soluble protein abundant in WAT (Samad et al., 1997),
we have tested whether WAT7 binds to DDCN via mimicking
TGF-b. However, our experiments failed to support this possi-
bility (data not shown), consistent with the lack of TGF-b-sized
bands among WAT proteins immunoprecipitated with anti-
WAT7 antibodies (Figure 6B). Isolation of resistin in a screen
for proteins mimicking WAT7 (and therefore interacting with
DDCN) came as a surprise, as there is no published literature
directly linking DCN with this adipokine. According to our data,
resistin directly binds to DDCN, but not to glycanated DCN.
Resistin receptor has not been previously identified, which may
be explained by lack of DCN processing in cells used for expres-
sion cloning. Combined, our results indicate that DDCN serves
as a resistin receptor on ASC surface.
Our work uncovers a new interaction network operating in
adipose tissue. Resistin is established as a hormone secreted
predominantly by adipocytes in WAT and as a key regulator of
metabolism (Steppan et al., 2001). The association of resistin
with the inflammatory response, a hallmark of WAT overgrowth
(Nagaev et al., 2006), is tantalizing in light of increased DCN
expression in obesity. Resistin promotes cell proliferation (Cala-
bro et al., 2004) and migration (Mu et al., 2006), while it inhibits
adipogenesis (Kim et al., 2001). It appears striking that its re-
ported effects on preadipocyte physiology match those induced
by DDCN expression (Figures 7A–7C), which are distinct from
the reported inhibitory effects of full-length DCN on cell prolifer-
ation and migration, as well as on adipogenesis (Ferdous et al.,
2010; Yamaguchi and Ruoslahti, 1988), reproduced in our study.
At this point it is unclear whether DDCN inhibits adipocyte differ-
entiation or if it maintains the committed adipocyte in a less
advanced state of differentiation with better-accessible, smaller
lipid droplets in a state of activated lipolysis. Building upon
the existing hypothesis of resistin secreted by adipocytes
functioning as a feedback regulator of adipocyte differentiation
(Villena et al., 2002), we propose that its action on adipose
progenitors is executed via DDCN-mediated signaling.
In summary, our study demonstrates that it is possible to
direct probes to perivascular stromal cells in vivo in an organ-
specific manner. In the future, the cell surface interaction
between DDCN and resistin can be exploited for imaging orCell Stem Cell 9, 74–86, July 8, 2011 ª2011 Elsevier Inc. 83
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prospective ASC marker makes a step toward stromal cell tar-
geting applications, cell surface molecules differentially ex-
pressed on MSCs in other organs are yet to be identified. Other
peptides isolated in our study, based on their homing to lung,
muscle, and bone marrow stromal cells, set the foundation for
subsequent identification of protein interactions marking peri-
vasculature of these organs.
EXPERIMENTAL PROCEDURES
Cell Isolation and Culture
Female C57BL/6 mice were used. Mice were anesthetized with Avertin. Cells
from mixed subcutaneous and intraperitoneal WAT or control organs were
isolated by enzymatic digestion as described (Traktuev et al., 2008; Zhang
et al., 2009) and separated into populations by FACSAria/FacsDiva software
(BD Biosciences) with the following IgG clones: PE-conjugated anti-CD34
MEC14.7, APC-conjugated anti-CD31 MEC 13.3, and APC-Cy7-conjugated
CD45 30-F11 (BD Biosciences). Cells were grown in DMEM/10% fetal bovine
serum (FBS) on uncoated plastic.
Phage Library Screening
Randompeptide libraries based on the bacteriophage vector fUSE5 displaying
inserts CX7C, CX8C, and CX9C were admixed (1:1:1) to the combined 10
10
transforming unit (TU) for a synchronous biopanning in vivo (Kolonin et al.,
2006b). For the competitive homing experiment, 5 3 109 TU for each of
the 11 chosen phage clones were admixed and the combined 5.5 3 1010 TU
was injected. For validation of clones, 1 3 1010 TU was injected. After 1 hr
of circulation and heart perfusion with 10 ml of phosphate buffered saline
(PBS), WAT, femoral bone marrow, skeletal muscle, and lungs were collected.
Hematopoietic cells and ECs were depleted from cell suspensions of each
organ by Dynabeads (Invitrogen, Carlsbad, CA) coated with anti-TER119,
anti-CD31, and anti-CD45 antibodies (BD Biosciences); the remaining cells
were processed by FACS to purify CD34+CD31CD45 cells. Bound phages
were recovered by infection with K91 E. coli, quantified by TU counting, and
processed for sequencing as described (Kolonin et al., 2006b). For identifica-
tion of conserved amino acid motifs, ClustalW2 software was used.
Mouse Tissue and Cell Analysis by Immunofluorescence
Peptides chemically synthesized, cyclized via cysteines, purified to at least
95% purity (Genemed), and biotinylated were injected (500 mg) via tail vein
and left to circulate for 1 hr. For tissue analyses, organs were recovered after
heart perfusionwith 10ml PBS. Immunolocalization of antigenswas performed
in paraffin sections of formalin-fixed tissues as described (Arap et al., 2002;
Kolonin et al., 2006b) upon EDTA-based antigen retrieval, washing with
0.3% Triton X-100 and blocking in Serum-Free Protein Block (DAKO). Primary
antibodies (4C, 12–16 hr) or 1:20 Streptavidin-Cy3 (Zymed) and secondary
antibodies (RT, 1 hr) were applied in PBS/0.05% Tween-20. The following
primary antibodies were used: 1:500 rabbit anti-phage (Sigma-Aldrich),
1:150 goat anti-mouseCD31 (Santa Cruz Biotechnology), 1:150 rat anti-mouse
CD45 (eBiosciences), 1:150 rabbit anti-mouse PDGFRb (Epitomics), and 1:200
goat anti-mouse DCN (R&D Systems). Secondary IgG used were as follows:
donkey Alexa 488-conjugated (Invitrogen) and Cy3-conjugated (Jackson).
Nuclei were stainedwithHoechst 33258 or TOPRO3 (Invitrogen). Cells cultured
in Lab-Tek II chamber slides (Nalgene) were subjected to immunofluorescence
with 1:100 anti-GFP antibodies (Abcam or Genetex). Fluorescence images
were acquired with an Olympus IX70 and Magnafire software (Olympus).
Confocal images were acquired with TCS SP5/LAS AF software (Leica).
Isolation of Proteins by Affinity Chromatography
Cells were disrupted in PBS containing 0.2 mM phenylmethanesulpho-
nylfluoride/Roche protease inhibitor (PI) cocktail with a Dounce homogenizer;
centrifugation (15,000 3 g for 30 min at 4C) was performed to separate
soluble proteins from membrane pellet. Solubilization of membrane proteins
in PBS containing 1mMCaCl2, 1mMMgCl2, 50mMn-Octyl-beta-D-glucopyr-
anoside, and PI cocktail (column buffer) was performed as described (Nie84 Cell Stem Cell 9, 74–86, July 8, 2011 ª2011 Elsevier Inc.et al., 2008). For WAT7 receptor purification, 5 mg of a cysteine-cyclized
peptide (Genemed) was coupled (via C terminus) onto 0.25 ml of EDC Sephar-
ose (Pierce), and the column was equilibrated with column buffer containing
1% Triton X-100. Peptide-coupled resin was incubated with 40 mg of
membrane extract and washed with column buffer. Elution (0.5 ml fractions)
was performed with 1.0 mM peptides, followed by 0.1 M glycine (pH 2.8).
For panning on eluates, 2 ml of each fraction desalted using Microcon filter
(Millipore) was immobilized on plastic overnight at 4C followed by incubation
with 20 ml of 105 TU of phage clones for 1 hr at RT. Unbound phagewere exten-
sively washed off with PBS, and then the bound phages were quantified by
infection of K91 E. coli directly on the plate as described (Kolonin et al.,
2006a). The remainingWAT7-phage-binding fraction was subjected to sodium
dodecyl sulfate (SDS)-PAGE, and mass spectrometry protein identification in
WAT7-specific bands was performed (ProtTech). For purification of DDCN,
20 mg of anti-DCN antibodies were immobilized on Protein A/G beads (Pierce)
and incubated with 40 mg of membrane extract. Upon washing with Protein
A/G binding buffer (Pierce), the 40 kDa band was subjected to N-terminus mi-
crosequencing. Preimmune and postimmune rabbit antisera against cyclized
KLH-coupled cysteine-cyclized WAT7 were from Genemed. To validate anti-
body specificity, glutathione-S-transferase (GST)-tagged peptides were
produced by cloning fragments encoding the CX7C amino acids in-frame
with GST Tag into pGEX4T-1 vector and using the GST Bind kit (Novagen).
GST-conjugated peptide CKGGRAKDC and prohibitin, as well as peptide
mPep were described previously (Kolonin et al., 2004; Nie et al., 2008). Resis-
tin, binding to WAT7-specific antibodies, was pulled down from total mouse
WAT SVF extract as above, resolved by SDS-PAGE, and identified by Prot-
Tech. Cell surface protein biotinylation was performed as described (Kolonin
et al., 2004) using EZ-Link Sulfo-NHS-LC-Biotin (Pierce). For isolation of
biotinylated ASC proteins, streptavidin-coupled Dynabeads M270 (Invitrogen)
were used. Plasma membrane fraction was isolated using Qproteome PM kit
(QIAGEN).
Immunoblotting and Binding Assays
Protein preparations resolved on SDS-PAGE were blotted onto Immobilon-FL
membrane (Millipore), blocked with Odyssey blocking buffer (LI-COR), and
probed (in PBS/0.05% Triton X-100) with 1:1000 goat anti-DCN (R&D
Systems), 1:1000 rabbit anti-ANX2A (Aviva), 1:10,000 rabbit anti-mouse
b-actin (Abcam) antibodies, or 1:1000 preimmune and postimmune antisera
against WAT7. Signal was detected by Odyssey imaging system using anti-
goat IRDye 800CW or anti-rabbit IRDye 680 (LI-COR). Bovine DCN was from
Sigma-Aldrich, and NS0-expressed murine DCN was from R&D Systems.
Murine DCN cDNA was generated from WAT total RNA using SuperScript kit
(Invitrogen). For bacterial expression, full-length core DCNandDDCN isoforms
were produced by cloning fragments encoding amino acids 1–354 and 45–354
of mouse DCN cDNA or of full-length CLIC4 cDNA (OriGene), respectively,
in-frame with the His6 tag into pET28a vector. His6-tagged proteins were puri-
fied with His-Tag kit (Novagen). For ELISA binding assays, 100 ml of 10 mg/ml
His6-tagged proteins, NS0-expressed murine DCN, purified bovine DCN
(Sigma-Aldrich), or BSA was coated and immobilized onto 96-well Maxisorb
Immunoplates (NUNC) overnight at 4C, followed by blocking with 3% BSA,
and then incubating with 100 ml of indicated concentrations of WAT7, FLAG-
tagged mouse resistin produced in HEK293 cells (Enzo), or control FLAG-
BAP protein (Sigma-Aldrich). Bound peptides or FLAG-resistin were probed
with corresponding 1:2000 rabbit anti-peptide or 1:2000 rabbit anti-FLAG
(Sigma-Aldrich) antibodies followed by 1:5000 goat anti-rabbit HRP-conju-
gated antibodies (Millipore), with signal detection via Ultra-TMB (Pierce)
substrate and absorbance measurement at 450 nm.
Functional Assays
cDNA fragments coding for full-length mouse core DCN and DDCN isoforms
were cloned into pLVX-AcGFP-C1 vector; lentivirus production in Lenti-X
293T cells using Lenti-X HTX was according to the manufacturer’s protocol
(Clontech). Lentivirus harboring vector alone,DCN, orDDCNwasused to trans-
duceNIH 3T3-L1 cells (ATCC). After selection of stable cells lines in puromycin-
containing medium, passage 2 lentivirus transductants were used in functional
studies. Formeasuring cell proliferation by theMTT assay, 5000 cells plated on
a 96-well plate were treated with CellTiter-Blue reagent (Promega) at the indi-
cated time points for 4 hr at 37C, after which the fluorescence was measured
Cell Stem Cell
Resistin-Decorin Interaction Marks Adipose MSCsat 560/590 nm. For measuring cell migration, 25,000 cells were starved for 2 hr
in DMEM/0.1% FBS and then seeded in the same media on a transwell insert
(5 mM pore). The insert was placed on top of the lower chamber containing
DMEM/10% FBS, and cells were allowed tomigrate to the bottom of the trans-
well for 12 hr, fixed, stained with Hematoxylin, and counted. Adipogenesis was
induced in DMEM/10% FBS containing 0.5 mM IBMX, 1.7 mM insulin, 1 mM
dexamethasone, and 0.2 mM indomethacin replaced after 72 hr with DMEM/
10% FBS containing 1.7 mM insulin refreshed every 2 days.
Statistical Analysis
All statistical analysis was performed by using the Student’s t test with signif-
icance being assigned to p < 0.05.
SUPPLEMENTAL INFORMATION
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